Related Experiment Videos

A simple infection model using pre-colonized implants to reproduce rat chronic Staphylococcus aureus osteomyelitis

M Monzón1, F García-Alvarez, A Laclériga

  • 1CSIC-SIA, Department of Animal Health, Zaragoza, Spain.

Insights

Developing new treatments for Staphylococcus aureus implant infections is crucial. This study presents a novel rat model for testing antibiotic effectiveness against these challenging biofilms, showing cefuroxime and vancomycin inhibit bone colonization.

Area of Science:

  • Infectious Diseases
  • Biomedical Engineering
  • Pharmacology

Background:

  • Staphylococcus aureus biofilms on medical implants cause persistent infections, resistant to antibiotics.
  • Effective antibiotic susceptibility testing for biofilm bacteria is lacking.
  • Chronic osteomyelitis requires innovative infection models for research.

Purpose of the Study:

  • To develop a novel, simplified in vivo rat model for chronic osteomyelitis caused by Staphylococcus aureus biofilms.
  • To evaluate the efficacy of common antibiotics against S. aureus biofilms in a clinically relevant setting.
  • To compare in vivo and in vitro antibiotic susceptibility of biofilm bacteria.

Main Methods:

  • A chronic osteomyelitis model was created in rats using pre-colonized stainless-steel implants.
  • Surgical site infection was established with 10^6 S. aureus biofilm bacteria.
  • Antibiotic treatment (cefuroxime, vancomycin, tobramycin, ciprofloxacin) was administered for 21 days, with infection assessed 42 days post-surgery.

Main Results:

  • The model successfully reproduced osteomyelitis in untreated animals.
  • Vancomycin and cefuroxime inhibited bone colonization by S. aureus.
  • Cefuroxime demonstrated the highest efficacy, reducing biofilm bacteria and sterilizing one implant.

Conclusions:

  • The developed rat model is effective for studying osteomyelitis and evaluating antibiotic treatments against S. aureus biofilms.
  • In vivo and in vitro antibiotic efficacy against S. aureus biofilms showed analogous results.
  • New antimicrobial strategies are urgently needed to combat antibiotic-resistant S. aureus biofilms on implants.

Related Concept Videos